TriSalus Life Sciences, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a TLSI research report →
Companytrisaluslifesci.com
TriSalus Life Sciences, Inc. , an immunotherapy company that develops and commercializes immunotherapies for the treatment of liver and pancreatic tumors. The company offers the TriNav Infusion System for hepatic arterial infusion of liver tumors; and the Pancreatic Retrograde Venous Infusion System for pancreatic tumors.
- CEO
- Mary T. Szela
- IPO
- 2021
- Employees
- 110
- HQ
- Westminster, CO, US
Price Chart
Valuation
- Market Cap
- $122.83M
- P/E
- -6.11
- P/S
- 2.74
- P/B
- 13.04
- EV/EBITDA
- -3.12
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 85.07%
- Op Margin
- -62.45%
- Net Margin
- -60.85%
- ROE
- 162.57%
- ROIC
- -47.18%
Growth & Income
- Revenue
- $45.15M · 53.41%
- Net Income
- $-39,227,000 · -18.04%
- EPS
- $-1.84 · -47.20%
- Op Income
- $-26,946,000
- FCF YoY
- 54.04%
Performance & Tape
- 52W High
- $7.95
- 52W Low
- $2.20
- 50D MA
- $4.11
- 200D MA
- $4.95
- Beta
- 0.56
- Avg Volume
- 350.69K
Get TickerSpark's AI analysis on TLSI
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 15, 26 | Marshak Richard | sell | 543 |
| May 15, 26 | Wahlstrom Mats | buy | 60,000 |
| May 15, 26 | Stansky Michael P | buy | 410,000 |
| May 15, 26 | Stansky Michael P | buy | 200,000 |
| May 15, 26 | Szela Mary T | buy | 39,682 |
| May 15, 26 | Patience David | buy | 7,100 |
| May 15, 26 | Gordon Gary B. | buy | 10,000 |
| May 14, 26 | HICKS KERRY R | other | 28,201 |
| May 14, 26 | HICKS KERRY R | other | 56,403 |
| May 14, 26 | Wahlstrom Mats | other | 75,204 |
Our TLSI Coverage
We haven't published any research on TLSI yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate TLSI Report →